BANK OF AMERICA CORP /DE/ - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 34 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$0580.0%0.00%
Q1 2022$058
-81.1%
0.00%
Q4 2021$0307
-58.1%
0.00%
Q3 2021$0733
+505.8%
0.00%
Q2 2021$0121
+108.6%
0.00%
Q1 2021$0580.0%0.00%
Q4 2020$0580.0%0.00%
Q3 2020$0580.0%0.00%
Q2 2020$0580.0%0.00%
Q1 2020$058
-22.7%
0.00%
Q4 2019$075
+29.3%
0.00%
Q3 2019$058
-81.6%
0.00%
Q2 2019$03160.0%0.00%
Q1 2019$03160.0%0.00%
Q4 2018$0
-100.0%
316
-23.5%
0.00%
Q3 2018$1,0004130.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 960,680$655,0000.02%
Virtu Financial LLC 466,704$318,0000.02%
tru Independence LLC 60,000$30,0000.01%
Jacobi Capital Management LLC 18,500$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,300$75,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 576,927$393,0000.00%
Stratos Wealth Partners, LTD. 10,850$7,0000.00%
NewEdge Advisors, LLC 14,187$10,0000.00%
Sowell Financial Services LLC 74$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders